{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-22-004603","form_type":"8-K","ticker":"UEEC","cik":"0001096938","company_name":"United Health Products, Inc.","filed_at":"2022-06-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:59.731523+00:00","generated_at":"2026-06-24T23:31:37.140496+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"United Health Products settles SEC investigation; former CEO to disgorge $1.02M to company","bullets":["SEC settlement requires permanent injunctions and $450,000 civil penalty payable over 270 days.","Former CEO Douglas Beplate to pay $1,020,000 disgorgement to UHP over next six months.","CEO Brian Thom's RSU grant increased 15% to 13.225M shares; vesting upon FDA premarket approval jumps from 5% to 20%.","Independent Director Robert Denser granted 1M RSUs vesting upon $30M cumulative revenue or change of control."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-22-004603","json":"https://secwatch.observer/filing/0001477932-22-004603.json","markdown":"https://secwatch.observer/filing/0001477932-22-004603.md","text":"https://secwatch.observer/filing/0001477932-22-004603.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1096938/000147793222004603/0001477932-22-004603-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1096938/000147793222004603/ueec_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T23:31:37.140496+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}